GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » Cash, Cash Equivalents, Marketable Securities

Kanabo Group (LSE:KNB) Cash, Cash Equivalents, Marketable Securities : £1.68 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group Cash, Cash Equivalents, Marketable Securities?

Kanabo Group's quarterly cash, cash equivalents, marketable securities increased from Dec. 2022 (£3.70 Mil) to Jun. 2023 (£4.44 Mil) but then stayed the same from Jun. 2023 (£4.44 Mil) to Dec. 2023 (£1.68 Mil).

Kanabo Group's annual cash, cash equivalents, marketable securities declined from Dec. 2021 (£4.48 Mil) to Dec. 2022 (£3.70 Mil) and declined from Dec. 2022 (£3.70 Mil) to Dec. 2023 (£1.68 Mil).


Kanabo Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Kanabo Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group Cash, Cash Equivalents, Marketable Securities Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 0.60 0.38 4.48 3.70 1.68

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.48 4.96 3.70 4.44 1.68

Kanabo Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Kanabo Group  (LSE:KNB) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Kanabo Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Kanabo Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Kanabo Group (LSE:KNB) Business Description

Industry
Traded in Other Exchanges
Address
137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom, Israel, and others.

Kanabo Group (LSE:KNB) Headlines

No Headlines